rs587776896
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001159773.2(CANT1):c.228dupC(p.Trp77fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000273 in 1,503,368 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000056 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )
Consequence
CANT1
NM_001159773.2 frameshift
NM_001159773.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.82
Genes affected
CANT1 (HGNC:19721): (calcium activated nucleotidase 1) This protein encoded by this gene belongs to the apyrase family. It functions as a calcium-dependent nucleotidase with a preference for UDP. Mutations in this gene are associated with Desbuquois dysplasia with hand anomalies. Alternatively spliced transcript variants have been noted for this gene.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-78997394-A-AG is Pathogenic according to our data. Variant chr17-78997394-A-AG is described in ClinVar as [Likely_pathogenic]. Clinvar id is 31014.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CANT1 | NM_001159773.2 | c.228dupC | p.Trp77fs | frameshift_variant | 3/5 | ENST00000392446.10 | NP_001153245.1 | |
CANT1 | NM_001159772.2 | c.228dupC | p.Trp77fs | frameshift_variant | 4/6 | NP_001153244.1 | ||
CANT1 | NM_138793.4 | c.228dupC | p.Trp77fs | frameshift_variant | 2/4 | NP_620148.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CANT1 | ENST00000392446.10 | c.228dupC | p.Trp77fs | frameshift_variant | 3/5 | 1 | NM_001159773.2 | ENSP00000376241.4 |
Frequencies
GnomAD3 genomes AF: 0.0000558 AC: 8AN: 143258Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
8
AN:
143258
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 248540Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135170
GnomAD3 exomes
AF:
AC:
7
AN:
248540
Hom.:
AF XY:
AC XY:
2
AN XY:
135170
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000243 AC: 33AN: 1360110Hom.: 0 Cov.: 36 AF XY: 0.0000207 AC XY: 14AN XY: 675564
GnomAD4 exome
AF:
AC:
33
AN:
1360110
Hom.:
Cov.:
36
AF XY:
AC XY:
14
AN XY:
675564
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000558 AC: 8AN: 143258Hom.: 0 Cov.: 32 AF XY: 0.0000432 AC XY: 3AN XY: 69448
GnomAD4 genome
AF:
AC:
8
AN:
143258
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
69448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Desbuquois dysplasia 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The CANT1 c.228dupC (p.Trp77LeufsTer13) variant results in a frameshift, and is predicted to result in premature termination of the protein. The p.Trp77LeufsTer13 has been reported in two studies and found in a total of three individuals affected with Desbuquois dysplasia, including one in a homozygous state and two in a compound heterozygous state (Furuichi et al. 2011; Laccone et al. 2011). The variant was absent from 200 control individuals and is not found in the 1000 Genomes Project, the Exome Sequencing Project, Exome Aggregation Consortium, or the Genome Aggregation Database in a region of good sequence coverage so the variant is presumed to be rare. Based on the potential impact of frameshift variants and the evidence, the p.Trp77LeufsTer13 variant is classified as likely pathogenic for Desbuquois dysplasia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2011 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | This sequence change creates a premature translational stop signal (p.Trp77Leufs*13) in the CANT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CANT1 are known to be pathogenic (PMID: 19853239, 21037275, 22539336). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Desbuquois dysplasia (PMID: 21037275, 21654728). ClinVar contains an entry for this variant (Variation ID: 31014). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2023 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 21037275, 34602954, 20358610, 21654728, 31847883) - |
Desbuquois dysplasia 1;C4540251:Epiphyseal dysplasia, multiple, 7 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 28, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at